Local Targeting of NAD+ Salvage Pathway Alters the Immune Tumor Microenvironment and Enhances Checkpoint Immunotherapy in Glioblastoma
Ming Li, Ameya R. Kirtane, Juri Kiyokawa, Hiroaki Nagashima, Aaron Lopes, Zain A. Tirmizi, Christine K. Lee, Giovanni Traverso, Daniel P. Cahill, Hiroaki Wakimoto
Abstract
In the original version of this article (1), the original version of Fig. 4C used two different exposures of the same field of cells to represent two different treatment conditions. The authors provided a corrected version of Fig. 4C and the error has been corrected in the latest online HTML and PDF versions of the article. The authors regret this error.
Topics & Concepts
GlioblastomaImmunotherapyRegretTumor microenvironmentCancer researchImmune checkpointCancer immunotherapyImmune systemMedicineImmunologyComputer scienceTumor cellsMachine learningNanoplatforms for cancer theranosticsAdenosine and Purinergic SignalingPeptidase Inhibition and Analysis